Stripes, an investment company, led a $70m Series D round in Hello Heart, a providor of cardiovascular digital therapeutics, with participation from Maven Ventures, BlueRun Ventures, IVP, and Resolute Ventures. “The round was oversubscribed. We are a baby unicorn and are on our way to becoming a fully-fledged unicorn. I’d rather not become a unicorn at this stage as we have already been diluted enough. We have already achieved a very respectable valuation, but the only valuation worth thinking about is the valuation six months after going public,” Maayan Cohen, Hello Heart Co-Founder and CEO.